CoCensys Inc. Reports Net Loss of $629,000 for Second Quarter

CoCensys Inc., an Irvine pharmaceutical company, reported a net loss of $629,000, or 3 cents a share, for the second quarter, compared with a net loss of $5.8 million, or 36 cents a share, for the comparable period last year. Revenue rose to $6.9 million from $1.9 million. For the six-month period, the net loss was $6.2 million, or 29 cents a share, compared with a year-earlier net loss of $11.5 million, or 74 cents a share. Revenue increased to $8.6 million from $2.1 million.